Stenting may offer new hope for tough stroke cases

NCT ID NCT06472336

Recruiting now Disease control Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two treatments for stroke patients whose brain arteries remain blocked after initial clot removal, due to underlying hardening of the arteries (atherosclerosis). About 498 participants will be randomly assigned to receive either urgent stenting or continued standard therapy. The goal is to see if stenting leads to better functional recovery and less disability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: intracranial stent
What this could lead to: If successful, this could provide a better treatment option for stroke patients whose arteries remain blocked after initial therapy, potentially reducing disability.
What could go wrong: This is a mid-stage trial with 498 participants, so results are not yet proven. Stenting carries risks like bleeding or further blockage, and the benefit over standard care is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral artery occlusion cerebral atherosclerosis intracranial arteriosclerosis ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL ATHEROSCLEROSIS STROKE STROKE, ACUTE ISCHEMIC

Contacts and locations

Locations

University Hospital Basel, Department of Interventional and Diagnostical Neuroradiology
RECRUITING

Basel, Canton of Basel-City, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.